Loading viewer...
report
Format: PDF report
This Public Assessment Report details the scientific discussion and approval process for Sorafenib Alvogen 200 mg, a treatment for hepatocellular and renal cell carcinoma.
report
Equinox Gold
report
PT Adaro Energy
report
General Electric
report
Acushnet Holdings